{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:34:00Z","timestamp":1794332040764,"version":"4.9.0"},"reference-count":47,"publisher":"The Journal of Rheumatology","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Rheumatol"],"published-print":{"date-parts":[[2017,1]]},"abstract":"<jats:sec><jats:title>Objective.<\/jats:title><jats:p>To compare baseline disease activity and treatment effectiveness in biologic-naive patients with nonradiographic axial spondyloarthritis (nr-axSpA) and ankylosing spondylitis (AS) who initiate tumor necrosis factor inhibitor (TNFi) treatment and to study the role of potential confounders (e.g., HLA-B27 status).<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods.<\/jats:title><jats:p>Observational cohort study based on prospectively registered data in the nationwide DANBIO registry. We used Kaplan-Meier plots, Cox, and logistic regression analyses to study the effect of diagnosis (nr-axSpA vs AS) and potential confounders (sex\/age\/start yr\/HLA-B27\/disease duration\/TNFi-type\/smoking\/baseline disease activity) on TNFi adherence and response [e.g., Bath Ankylosing Spondylitis Activity Index (BASDAI) 50%\/20 mm].<\/jats:p><\/jats:sec><jats:sec><jats:title>Results.<\/jats:title><jats:p>The study included 1250 TNFi-naive patients with axSpA (29% nr-axSpA, 50% AS, 21% lacked radiographs of sacroiliac joints). Patients with nr-axSpA were more frequently women (50%\/27%) and HLA-B27\u2013negative (85\/338 = 25%), compared to AS (81\/476 = 17%; p &lt; 0.01). At TNFi start patients with nr-axSpA had higher visual analog scale scores [median (quartiles)] for pain: 72 mm (55\u201384)\/65 mm (48\u201377); global: 76 mm (62\u201388)\/68 mm (50\u201380); fatigue: 74 mm (55\u201385)\/67 mm (50\u201380); and BASDAI: 64 (54\u201377)\/59 (46\u201371); all p &lt; 0.01. However, patients with nr-axSpA had lower C-reactive protein: 7 mg\/l (3\u201317)\/11 mg\/l (5\u201322); and BAS Metrology Index: 20 (10\u201340)\/40 (20\u201350); all p &lt; 0.01. Median (95% CI) treatment adherence was poorer in nr-axSpA than in AS: 1.59 years (1.15\u20132.02) versus 3.67 years (2.86\u20134.49), p &lt; 0.0001; but only in univariate and not confounder-adjusted analyses (p &gt; 0.05). Response rates were similar in AS and nr-axSpA (p &gt; 0.05). HLA-B27 negativity was associated with poorer treatment adherence [HLA-B27 negative\/positive, nr-axSpA: HR 1.74 (1.29\u20132.36), AS: HR 2.04 (1.53\u20132.71), both p &lt; 0.0001]; and lower response rates (nr-axSpA: 18\/61 = 30% vs 93\/168 = 55%; AS: 17\/59 = 29% vs 157\/291 = 54%, both p &lt; 0.05).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion.<\/jats:title><jats:p>In this nationwide cohort, patients with nr-axSpA had higher subjective disease activity at start of first TNFi treatment, but similar outcomes to patients with AS after confounder adjustment. HLA-B27 positivity was associated with better outcomes irrespective of axSpA subdiagnosis.<\/jats:p><\/jats:sec>","DOI":"10.3899\/jrheum.160958","type":"journal-article","created":{"date-parts":[[2016,12,2]],"date-time":"2016-12-02T02:20:24Z","timestamp":1480645224000},"page":"59-69","source":"Crossref","is-referenced-by-count":55,"title":["Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry"],"prefix":"10.3899","volume":"44","author":[{"given":"Bente","family":"Glintborg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inge J.","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"\u00d8stergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdiweli A.","family":"Mohamoud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels S.","family":"Krogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Hendricks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lis S.","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johnny L.","family":"Raun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcin R.","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Danielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randi","family":"Pelck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Nordin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens K.","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorte G.A.","family":"Kraus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R.","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inger M.J.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jakob","family":"Esbesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Schlemmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne G.","family":"Loft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabil","family":"al Chaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Salomonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete L.","family":"Hetland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2262","published-online":{"date-parts":[[2016,12,1]]},"reference":[{"key":"2018112909365491000_44.1.59.1","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.108233"},{"key":"2018112909365491000_44.1.59.2","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2008.104018"},{"key":"2018112909365491000_44.1.59.3","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270401"},{"key":"2018112909365491000_44.1.59.4","doi-asserted-by":"publisher","DOI":"10.1002\/art.37829"},{"key":"2018112909365491000_44.1.59.5","doi-asserted-by":"publisher","DOI":"10.1097\/BOR.0000000000000071"},{"key":"2018112909365491000_44.1.59.6","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.145995"},{"key":"2018112909365491000_44.1.59.7","doi-asserted-by":"publisher","DOI":"10.1002\/art.24024"},{"key":"2018112909365491000_44.1.59.8","doi-asserted-by":"publisher","DOI":"10.1002\/acr.21688"},{"key":"2018112909365491000_44.1.59.9","doi-asserted-by":"publisher","DOI":"10.1002\/art.38140"},{"key":"2018112909365491000_44.1.59.10","doi-asserted-by":"publisher","DOI":"10.1517\/13543784.2014.899351"},{"key":"2018112909365491000_44.1.59.11","doi-asserted-by":"publisher","DOI":"10.1002\/art.24483"},{"key":"2018112909365491000_44.1.59.12","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.041137"},{"key":"2018112909365491000_44.1.59.13","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.151027"},{"key":"2018112909365491000_44.1.59.14","unstructured":"Concept paper on clinical investigation of medicinal products for the treatment of axial spondyloarthritis. 2015. [Internet. Accessed October 26, 2016.] Available from: www.ema.europa.eu\/docs\/en_GB\/document_library\/Scientific_guideline\/2015\/04\/WC500185187.pdf"},{"key":"2018112909365491000_44.1.59.15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/art.39298","article-title":"American College of Rheumatology\/Spondylitis Association of America\/Spondyloarthritis Research and Treatment Network 2015 Recommendations for the Treatment of Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis","volume":"68","author":"Ward","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2018112909365491000_44.1.59.16","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201766"},{"key":"2018112909365491000_44.1.59.17","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1002\/art.38721","article-title":"Symptomatic efficacy of etanercept and its effects on objective signs of inflammation in early nonradiographic axial spondyloarthritis: a multicenter, randomized, double-blind, placebo-controlled trial","volume":"66","author":"Dougados","year":"2014","journal-title":"Arthritis Rheumatol"},{"key":"2018112909365491000_44.1.59.18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1186\/s13075-015-0897-6","article-title":"Comparison of non-radiographic axial spondyloarthritis and ankylosing spondylitis patients--baseline characteristics, treatment adherence, and development of clinical variables during three years of anti-TNF therapy in clinical practice","volume":"17","author":"Wallman","year":"2015","journal-title":"Arthritis Res Ther"},{"key":"2018112909365491000_44.1.59.19","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.150372"},{"key":"2018112909365491000_44.1.59.20","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keq309"},{"key":"2018112909365491000_44.1.59.21","unstructured":"Danish Rheumatological Database. [Internet. Accessed October 26, 2016.] Available from: https:\/\/danbio-online.dk"},{"key":"2018112909365491000_44.1.59.22","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2005.040758"},{"key":"2018112909365491000_44.1.59.23","doi-asserted-by":"publisher","DOI":"10.1002\/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F"},{"key":"2018112909365491000_44.1.59.24","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2003.016717"},{"key":"2018112909365491000_44.1.59.25","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2010.138594"},{"key":"2018112909365491000_44.1.59.26","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2393"},{"key":"2018112909365491000_44.1.59.27","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.39300","article-title":"Editorial: Shifting the goal posts: treatment recommendations for ankylosing spondylitis and the newly defined condition of nonradiographic axial spondyloarthritis","volume":"68","author":"Taylor","year":"2016","journal-title":"Arthritis Rheumatol"},{"key":"2018112909365491000_44.1.59.28","doi-asserted-by":"publisher","DOI":"10.7861\/clinmedicine.12-4-324"},{"key":"2018112909365491000_44.1.59.29","unstructured":"UK National Institute for Health and Care Excellence . Adalimumab, etanercept and infliximab for ankylosing spondylitis. [Internet. Accessed October 26, 2016.] Available from: www.nice.org.uk\/guidance\/ta143"},{"key":"2018112909365491000_44.1.59.30","unstructured":"Dansk Reumatologisk Selskab. Guideline for treatment of axial spondyloarthritis in Denmark. [Internet. In Danish. Accessed October 26, 2016.] Available from: www.danskreumatologiskselskab.dk\/fileadmin\/DRS\/kliniskeretningslinjer\/SpA_retningslinie_DRS.pdf"},{"key":"2018112909365491000_44.1.59.31","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbspin.2011.01.013"},{"key":"2018112909365491000_44.1.59.32","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket164"},{"key":"2018112909365491000_44.1.59.33","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2013-204231"},{"key":"2018112909365491000_44.1.59.34","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205322"},{"key":"2018112909365491000_44.1.59.35","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202389"},{"key":"2018112909365491000_44.1.59.36","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2009.124446"},{"key":"2018112909365491000_44.1.59.37","doi-asserted-by":"crossref","first-page":"R7","DOI":"10.1186\/ar2591","article-title":"Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study","volume":"11","author":"Sokka","year":"2009","journal-title":"Arthritis Res Ther"},{"key":"2018112909365491000_44.1.59.38","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-206811"},{"key":"2018112909365491000_44.1.59.39","doi-asserted-by":"publisher","DOI":"10.1002\/art.37876"},{"key":"2018112909365491000_44.1.59.40","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201933"},{"key":"2018112909365491000_44.1.59.41","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2011.152975"},{"key":"2018112909365491000_44.1.59.42","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2014-205432"},{"key":"2018112909365491000_44.1.59.43","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110070"},{"key":"2018112909365491000_44.1.59.44","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00296-014-2955-9","article-title":"Fibromyalgia in patients with axial spondyloarthritis: epidemiological profile and effect on measures of disease activity","volume":"34","author":"Salaffi","year":"2014","journal-title":"Rheumatol Int"},{"key":"2018112909365491000_44.1.59.45","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s13075-016-0943-z","article-title":"Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis","volume":"18","author":"Bello","year":"2016","journal-title":"Arthritis Res Ther"},{"key":"2018112909365491000_44.1.59.46","doi-asserted-by":"crossref","unstructured":"Kroon FP van der Burg LR Ramiro S Landewe RB Buchbinder R Falzon L Non-steroidal anti-inflammatory drugs (NSAIDs) for axial spondyloarthritis (ankylosing spondylitis and non-radiographic axial spondyloarthritis). Cochrane Database Syst Rev 2015;(7):CD010952.","DOI":"10.1002\/14651858.CD010952.pub2"},{"key":"2018112909365491000_44.1.59.47","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-201370"}],"container-title":["The Journal of Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.3899\/jrheum.160958","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T00:38:38Z","timestamp":1749775118000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jrheum.org\/lookup\/doi\/10.3899\/jrheum.160958"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,1]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2017,1,1]]},"published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.3899\/jrheum.160958"],"URL":"https:\/\/doi.org\/10.3899\/jrheum.160958","relation":{},"ISSN":["0315-162X","1499-2752"],"issn-type":[{"value":"0315-162X","type":"print"},{"value":"1499-2752","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,1]]}}}